StockData

Liminatus Pharma, Inc. (LIMN) stock

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$2.68−0.13 (-4.63%)

Close on Nov 18, 2026Market cap $179.99MP/E –Yield –

Liminatus Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Liminatus Pharma's market cap was $164.56M on Nov 11, 2026, against $1.41B a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$164.56M-80.1%
2025Dec 31, 2025$825.47M–

More Liminatus Pharma figures

See a number that looks wrong?